Skeletal Radiology

, Volume 48, Issue 3, pp 437–443 | Cite as

Plexiform fibrohistiocytic tumor: imaging features and clinical findings

  • Marcus GhumanEmail author
  • Sinchun Hwang
  • Cristina R. Antonescu
  • David M. Panicek
Scientific Article



To describe the imaging features of plexiform fibrohistiocytic tumor and its associated clinical findings.

Materials and methods

An institutional database was searched to identify all patients with a pathological diagnosis of plexiform fibrohistiocytic tumor. The electronic medical record was reviewed for relevant clinical data. Radiologic images of the primary tumor site were reviewed by two radiologists to assess primary, residual, or recurrent tumor with respect to tumor location, size, morphology, MR signal characteristics and enhancement, and involvement of adjacent structures.


Thirteen patients with imaging of the primary tumor site were identified [eight female, five male; mean age, 15.9 years (range, 3–41 years)]. Plexiform fibrohistiocytic tumor typically manifested as a solitary, painless, firm, slow-growing lesion centered in the subcutaneous tissues, with a predilection for the upper extremity or head and neck region. Most tumors had a purely plaque-like or infiltrative morphology at MRI; some demonstrated no round or oval mass. Tumors were predominantly isointense to muscle on T1-weighted imaging and hyperintense on fluid-sensitive imaging, and enhanced after gadolinium contrast administration. Five patients (38%) had residual tumor after initial surgery, resembling postoperative changes. No patient had recurrent tumor. One patient (8%) developed metastases to local lymph nodes and to the lung. No patient died from plexiform fibrohistiocytic tumor.


Plexiform fibrohistiocytic tumor often manifests as a plaque-like or infiltrative process, sometimes without a round or oval mass, most commonly in the subcutaneous tissues of the upper extremity or head and neck region. Residual tumor is often present after initial surgery, and may be indistinguishable from postoperative changes.


Plexiform fibrohistiocytic tumor Imaging MRI Soft tissue tumor 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.


  1. 1.
    Enzinger F, Zhang RY. Plexiform fibrohistiocytic tumor presenting in children and young adults. An analysis of 65 cases. Am J Surg Pathol. 1988;12(11):818–26.CrossRefGoogle Scholar
  2. 2.
    Moosavi C, Jha P, Fanburg-Smith JC. An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD. Ann Diagn Pathol. 2007;11(5):313–9.CrossRefGoogle Scholar
  3. 3.
    Fletcher CD. The evolving classification of soft tissue tumours—an update based on the new 2013 WHO classification. Histopathology. 2014;64(1):2–11.CrossRefGoogle Scholar
  4. 4.
    Remstein ED, Arndt CA, Nascimento AG. Plexiform fibrohistiocytic tumor: clinicopathologic analysis of 22 cases. Am J Surg Pathol. 1999;23(6):662–70.CrossRefGoogle Scholar
  5. 5.
    Harrill JC, Johnston RS. Plexiform fibrohistiocytic tumor of the foot: a case report. J Foot Ankle Surg. 2014;53(5):635–7.CrossRefGoogle Scholar
  6. 6.
    Ng E, Tandon AA, Ho BC, Chong BK. Characterising benign fibrous soft-tissue tumours in adults: why is it so difficult and what do we need to know? Clin Radiol. 2015;70(7):684–97.CrossRefGoogle Scholar
  7. 7.
    Yalcinkaya U, Uz Unlu M, Bilgen MS, Yazici Z. Plexiform fibrohistiocytic tumor of bone. Pathol Int. 2013;63(11):554–8.CrossRefGoogle Scholar
  8. 8.
    Yeo ED, Chung BM, Kim EJ, Kim WT. Infiltrating angiolipoma of the foot: magnetic resonance imaging features and review of the literature. Skelet Radiol. 2018;47(6):859–64.CrossRefGoogle Scholar
  9. 9.
    Ravi AK, Ram R, Lindberg MR, Pandey T. Diffuse infiltrative neurofibroma: a clinical, radiological, and histological conundrum. Skelet Radiol. 2014;43(12):1773–8.CrossRefGoogle Scholar
  10. 10.
    Lim R, Jaramillo D, Poussaint TY, Chang Y, Korf B. Superficial neurofibroma: a lesion with unique MRI characteristics in patients with neurofibromatosis type 1. AJR Am J Roentgenol. 2005;184(3):962–8.CrossRefGoogle Scholar
  11. 11.
    Chism CB, Crawford L, Tchakarov A, Al-Ibraheemi A. Beckmann NM. PTEN hamartoma of the soft tissue: the initial manifestation of an underlying PTEN hamartoma tumor syndrome in a 4-year-old female. Skelet Radiol. 2017;46(11):1591–5.CrossRefGoogle Scholar
  12. 12.
    Yoo HJ, Hong SH, Kang Y, et al. MR imaging of myxofibrosarcoma and undifferentiated sarcoma with emphasis on tail sign; diagnostic and prognostic value. Eur Radiol. 2014;24(8):1749–57.CrossRefGoogle Scholar
  13. 13.
    Lefkowitz RA, Landa J, Hwang S, et al. Myxofibrosarcoma: prevalence and diagnostic value of the “tail sign” on magnetic resonance imaging. Skelet Radiol. 2013;42:809–18.CrossRefGoogle Scholar
  14. 14.
    Lee HJ, Im JG, Goo JM, et al. Peripheral T-cell lymphoma: spectrum of imaging findings with clinical and pathologic features. Radiographics. 2003;23(1):7–26.CrossRefGoogle Scholar
  15. 15.
    Antonescu CR, Zhang L, Nielsen GP, Rosenberg AE, Dal Cin P, Fletcher CD. Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor. Genes Chromosom Cancer. 2011;50(10):757–64.CrossRefGoogle Scholar
  16. 16.
    O’Driscoll D, Athanasian E, Hameed M, Hwang S. Radiological imaging features and clinicopathological correlation of hemosiderotic fibrolipomatous tumor: experience in a single tertiary cancer center. Skelet Radiol. 2015;44(5):641–8.CrossRefGoogle Scholar
  17. 17.
    Gaetke-Udager K, Yablon CM, Lucas DR, Morag Y. Myxoinflammatory fibroblastic sarcoma: spectrum of disease and imaging presentation. Skelet Radiol. 2016;45(3):347–56.CrossRefGoogle Scholar
  18. 18.
    Salomao DR, Nascimento AG. Plexiform fibrohistiocytic tumor with systemic metastases: a case report. Am J Surg Pathol. 1997;21(4):469–76.CrossRefGoogle Scholar

Copyright information

© ISS 2018

Authors and Affiliations

  • Marcus Ghuman
    • 1
    Email author
  • Sinchun Hwang
    • 1
    • 2
  • Cristina R. Antonescu
    • 3
  • David M. Panicek
    • 1
    • 2
  1. 1.Department of RadiologyMemorial Sloan Kettering Cancer CenterNew YorkUSA
  2. 2.Weill Medical College of Cornell UniversityNew YorkUSA
  3. 3.Department of PathologyMemorial Sloan Kettering Cancer CenterNew YorkUSA

Personalised recommendations